Overview

SAP Depleter Dose Escalation Study in Healthy Volunteers

Status:
Completed
Trial end date:
2011-06-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to provide safety information and to define the optimal induction and short term maintenance regimen for GSK2315698 to deplete circulating SAP in healthy volunteers prior to assessing in patients
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline